Abstract:Nisin is an antimicrobial polypeptide produced by Lactococcus lactis and is believed nontoxic to humans. The objective of this study was to evaluate a nisin-based formulation for the treatment of bovine clinical mastitis in lactating dairy cattle. A total of 92 cows with 107 clinically mastitic quarters were randomly assigned to nisin- (48 cows with 51 quarters) and gentamicin (GM)-treated (44 cows with 56 quarters) groups. In the nisin-treated group, cows received an intramammary infusion of nisin at a dose of 2,500,000 IU; in the GM-treated group, intramammary infusion of GM was administered at a dose of 0.8 g. Results indicated that nisin offered a clinical cure rate similar to GM (90.2 vs. 91.1%) and no difference in bacteriological cure rate than GM-treated group (60.8 vs. 44.6%, respectively). Proportion of the quarters with milk somatic cell counts <500,000 cells/mL was not different in the nisin-treated group (50.0 and 47.8%) compared with the GM-treated group (33.3 and 37.3%) 1 and 2 wk after treatment. Of 17 Staphylococcus aureus isolates, 82.5% were resistant to penicillin, and 35.3% to GM, but none of them to nisin. Nisin therapy eliminated 54.5% (6 of 11) of S. aureus IMI, whereas GM eliminated 33.3% (2 of 6). Nisin in milk (4.5 +/- 0.8 IU/mL) was detected only at 12 h following intramammary infusion, which was much lower than the upper limit (500 mg/mL) allowed as preservative in milk by the China authority. Because of its efficacy in the treatment of bovine clinical mastitis, especially resistant Staph. aureus-caused IMI, as well as its safety in humans, nisin deserves further study to clarify its effects on mastitis caused by different mastitis pathogens on a larger scale.

Nisin extraction capacity of aqueous ethanol and methanol from a 2.5% preparation

Improving nitrogen source utilization from defatted soybean meal for nisin production by enhancing proteolytic function of Lactococcus lactis F44

Optimization of Medium Composition for Nisin Fermentation with Response Surface Methodology.

Preparation and antibacterial properties of high-methoxy pectin oligosaccharide -nisin nanoparticles

Preparation and antimicrobial activity of pectin-chitosan embedding nisin microcapsules

Liquid–liquid extraction of commercial and biosynthesized nisin by aqueous two-phase micellar systems

Improvement of nisin production by using the integration strategy of co-cultivation fermentation, foam fractionation and pervaporation

Extraction and Purification Nisin from Lactobacillus lactis and Determine the Optimal Conditions for its Production and Evaluation its Effectiveness in Food Preservation

Harvest of nisin from fermentation broth using foam separation with the assistance of ultrasonic treatment: Foam property evaluation and antimicrobial activity retention

Efficacy of nisin in treatment of clinical mastitis in lactating dairy cows.

Comparison of Different Nisin Separation and Concentration Methods: Industrial and Cost-Effective Perspectives

Nisin Purification from a Cell-Free Supernatant by Electrodialysis in a Circular Economy Framework

One step purification of active nisin by electrodialysis from a commercial product

Screening, characterization and mechanism of a potential stabiliser for nisin nanoliposomes with high encapsulation efficiency

Aqueous Two-Phase Micellar System for Nisin Extraction in the Presence of Electrolytes

Nisin-loaded poly-l-lactide nano-particles produced by CO2 anti-solvent precipitation for sustained antimicrobial activity

Formation and Optimization of Chitosan-Nisin Microcapsules and Its Characterization for Antibacterial Activity

Nisin Production with Aspects on Its Practical Quantification

Observasion of Nisin for Bovine Mastitis Therapy